Botanical technology company Eybna is heading to ICBC Berlin this year, bringing its BNA™ AI technology platform and receptor-specific botanical formulations to booth #346.
"Our booth will showcase our ability to customize formulations to clients' aroma, functionality, and market requirements," said Victoria Dang from Eybna. The company's all-natural, GMP-certified ingredients are engineered to produce measurable biological effects across vapes, pre-rolls, edibles, and beverages, she said. CEO and co-founder Nadav Eyal is also confirmed on a panel during the event.
© Eybna
Europe is where Eybna is placing its bets. "As regulations continue to change, licensees and manufacturers need reliable, scalable solutions to produce consistent products for the EU market," Victoria said. "In addition to being FSSC and GMP-certified, Eybna operates from Germany, USA, and Israel, allowing for production reliability and formulation support across the globe."
The regulatory picture, though, remains messy. "One of the biggest challenges in Europe is that cannabis regulation differs widely by country, with each EU member state or European country setting its own rules for medical, recreational, and CBD products," Victoria said. "This patchwork framework creates complexity for companies trying to operate across borders." Her view is that the industry has a role to play. "Those of us in the industry today can collaborate on unified, evidence-based standards, share data demonstrating public health and economic benefits, and engage policymakers with responsible, compliance-first proposals."
Eybna is also trying to shift how the industry thinks about terpene formulations. For most, they are still primarily an aroma and flavor tool. "With the combination of specific terpenes, our Receptor-Specific™ Formulations provide measurable outcomes, such as calm, focus, sleep, and uplift," Victoria concluded.
For more information:
Eybna
eybna.com
